What is Viridian Therapeutics, Inc.'s total revenue?

Viridian Therapeutics, Inc. (VRDN) reported total revenue of $141K in Q1 2026.

How has Viridian Therapeutics, Inc.'s total revenue changed year-over-year?

Viridian Therapeutics, Inc.'s total revenue increased by 95.8% year-over-year, from $72K to $141K.

What is the long-term trend for Viridian Therapeutics, Inc.'s total revenue?

Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s total revenue has grown at a 121.1% compound annual growth rate (CAGR), from $2.96M to $70.85M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Viridian Therapeutics, Inc. VRDN Total Revenue

Total Revenue at other companies

AmgenAMGN

$8.62B+5.8%

ANI PharmaceuticalsANIP

$237.46M+20.5%

Vir Biotechnology, Inc.VIR

-$29K-101%

Nektar TherapeuticsNKTR

$10.86M+3.8%

Syndax PharmaceuticalsSNDX

$64.86M+224%

Ultragenyx PharmaceuticalRARE

$136M-2.2%

Segments

By product

See full

Collaboration$135K—

License$6K—

Other financials

Income statement

See full

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s total revenue?: Viridian Therapeutics, Inc. (VRDN) reported total revenue of $141K in Q1 2026.
How has Viridian Therapeutics, Inc.'s total revenue changed year-over-year?: Viridian Therapeutics, Inc.'s total revenue increased by 95.8% year-over-year, from $72K to $141K.
What is the long-term trend for Viridian Therapeutics, Inc.'s total revenue?: Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s total revenue has grown at a 121.1% compound annual growth rate (CAGR), from $2.96M to $70.85M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.